๐Ÿงฌ MC4R Agonistโœ… FDA Approved (IMCIVREE)๐ŸŽฏ Genetic Obesity

Setmelanotide Tracker App

Track Every Dose. See Every Trend.

Shotlee is the free way to track your Setmelanotide protocol from day one. Setmelanotide is a Melanocortin 4 receptor (MC4R) agonist by Rhythm Pharmaceuticals. Log every injection, monitor your weight trajectory, record side effects, and build a clean data history that you can review with your healthcare provider at any time.

Key Tracking Features

01

Precise dose logging with timestamps and injection site rotation

02

Visual weight and body composition trend charts over time

03

Side effect correlation to help optimize your protocol with your doctor

Clinical Snapshot

POMC/PCSK1 (52 wks)

~10%+

Significant weight loss and dramatic hunger reduction in patients with POMC or PCSK1 deficiency obesity.

Hunger Reduction

Dramatic

Patients reported life-changing reductions in hunger scores, often from insatiable to manageable levels.

What This Means for Your Tracking Right Now

Whether you are already on Setmelanotide or considering it as a future option, building clean tracking data now gives you a major advantage. Having historical weight, symptom, and dose records makes it far easier to evaluate how well any protocol is working for your body.

Use Shotlee to log your body weight trend, dose consistency, appetite changes, GI symptoms, blood pressure, and any lab markers your doctor recommends. If you ever switch medications, that historical data lets you compare outcomes with precision instead of guesswork.

Shotlee supports all major metabolic protocols today, so you can stay systematic regardless of which specific medication you are on.

Tracking Priorities in Shotlee

Weekly dose logs, side effect timing, body weight, waist measurements, and key lab snapshots are the highest-value signals to capture now in the Shotlee app.

Vital Protocol FAQs

Is Setmelanotide for general obesity?

Currently, IMCIVREE is FDA-approved specifically for rare genetic obesity caused by POMC, PCSK1, or LEPR pathway deficiencies. Expansion studies for other genetic obesity forms are ongoing. Track your treatment in Shotlee.

How is it different from GLP-1 drugs?

Completely different mechanism. Setmelanotide activates MC4R in the brain's hypothalamus to restore broken appetite signaling, while GLP-1 drugs work through incretin hormone pathways. Use Shotlee to track either approach.

Start Tracking Your Protocol Today

Track your Setmelanotide protocol with Shotlee and make every decision from clean, visible data instead of guesswork.

๐Ÿš€ Use Shotlee for Free